French Prime Minister Manuel Valls visits Ceva Santé Animale >
Libourne, 24 July 2015 – French Prime Minister Manuel Valls visited Ceva’s headquarters in Libourne, to meet Dr. Marc Prikazsky and other business leaders from the local Aquitaine region. Prime Minister Manuel Valls visits Ceva with Marc Prikazsky The Prime Minister was accompanied by a large delegation including Alain Rousset, President of the Aquitaine region. The company has recently...
Ceva posts strong double-digit growth again in H1 2015 >
Libourne 22 nd July 2015 - Consolidated sales of the Ceva Group reached €424m at the end of June 2015, representing growth of 16% and +12% at constant perimeter and exchange rates. Sales grew in all zones, except Europe which was stable versus last year, with strong performance in North America/Pacific region (+43%), Asia (+38%) and Latin America (+26%). All species are growing, especially Poultry...
Ceva posts strong double-digit growth again in 2014 >
Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23% and +14.1% at a constant perimeter and exchange rates.
Happy new year 2015 ! >
Ceva Santé Animale wishes you all the best for 2015 !
Ceva US Joins Fear Free™ Initiative As Inaugural Industry Sponsor >
Ceva today announced its commitment to Fear Free,™ an innovative initiative developed by “America’s Veterinarian” Dr. Marty Becker to in his words, “take the pet out of petrified and get pets back into practices.” The multi-year agreement aligns with Ceva’s leadership role and expertise in the area of pet behavior.
Ceva Santé Animale reinforces its pharmaceutical production capacity, opening a new plant at its headquarters in Libourne France >
Libourne, 3 October 2014 – Ceva Santé Animale, the global veterinary health group, has invested €18 million in renovating and extending its sterile products plant in Libourne. The new industrial facility was inaugurated on 3 October and will increase injectable drug production capacity.
Ceva merges all R&D activity and nominates Dr. Steve Chu as member of the Executive Committee >
Libourne 4th September 2014 - Ceva Santé Animale announced the appointment of Dr.Chu to its executive committee with responsibility for all R&D activities. The move recognises the growing importance of biotechnology and the resulting convergence of pharmaceutical and biological research. Dr.Chu joined Ceva in 2011 and has an outstanding record throughout his 30 year career in veterinary research,...
Mérieux Développement becomes a shareholder of Ceva Santé Animale >
Ceva Santé Animale announces the arrival of a new shareholder, Mérieux Développement, the investment company of Institut Mérieux.
Mid-year results >
Ceva attracts strong investor support for 4th LMBO and returns to double-digit growth in first 6 months of 2014
Ceva Santé Animale reorganizes its capital structure to bolster its international ambitions >
Libourne, June 11, 2014: The management of Ceva Santé Animale announces a reshaping of its capital structure through a new round of financing which strengthens its position as majority shareholder and welcomes new investors to support the group in a new phase of development. The new capital structure paves the way to the entry of Temasek who will invest alongside the managementas well as French...